Hamburg Center of NeuroScience (HCNS)
The HCNS constitutes a network of all neuroscientific activites at the UKE from the molecular level to clinical research. It provides numerous interfaces with institutes of the University of Hamburg.
The main mission of the HCNS is promoting and facilitating large collaborative research projects. Current examples are Sonderforschungsbereich 936 ( SFB 936 ) in systems neuroscience, the Priority Programme SPP 1665 , and several collaborative grants of the DFG, BMBF and EU such as NETS , NEU² and IMAGEN . A second goal of equal importance is optimizing student training and career development of researchers in the neurosciences.
The HCNS comprises more then 400 scientists and doctoral students of 18 institutes and clinical departments of the UKE and the University of Hamburg. The HCNS follows the general philosophy that modern neuroscientific methods make it possible to understand normal and pathological function of the brain and, by understanding disease mechanisms, develop novel and more effective treatments for diseases. The main topics in the HCNS are neuronal plasticity, learning and memory, regeneration of the nervous system, neuroscience of emotion and cognition, mechanisms of neurodegeneration, mechanisms of signal transmission and communication in the brain from the molecular to the systems level, molecular basis, diagnostics and therapy of neurological and psychiatric disease. Significant innovations and landmark results have been discovered by members of the HCNS in the past and are now systematically pursued.
Several departments have strategically focused on brain plasticity and the question how brain plasticity can be modulated in order to treat neurological diseases, e.g., by applying electrical brain stimulation in stroke patients or patients suffering from Parkinson's disease.
Other scientists in the HCNS have generated striking data on the function of the human reward system and its impact on problem gambling in adolescents. These data have lead to a unique multicenter trial on teenager development sponsored in the 6th European Framework program.
Further landmarks are new molecular diagnostic tests for Alzheimer dementia and prion diseases and recent neuroimmunological data of the HCNS that facilitate the development of innovative treatment strategies against multiple sclerosis. In basic science, translational and clinical research, the HCNS has numerous regional, national and international collaborations with other university-level institutions (e.g., DESY, Max-Planck-Institute, National Institutes of Health, University College of London, Harvard Medical School) as well as private public partnerships. The future perspective of the HCNS is to expand and improve the local neuroscience network in order to make Hamburg one of the leading neuroscience centers world-wide.